INTRAVENOUSLY ADMINISTERED GOLIMUMAB SIGNIFICANTLY IMPROVES HEALTH RELATED QUALITY OF LIFE AND WORK PRODUCTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS OF A PHASE III, PLACEBO-CONTROLLED TRIAL

被引：0
|
作者：
Westhovens, R. [1 ]
Weinblatt, M. E. [2 ]
Han, C. [3 ]
Gathany, T. [3 ]
Kim, L. [4 ]
Mack, M. [5 ]
Lu, J. [4 ]
Baker, D. [4 ]
Mendelsohn, A. [6 ]
Bingham, C. [7 ]
机构：
[1] Univ Hosp Gasthuisberg, Louvain, Belgium
[2] Brigham & Womens Hosp, Boston, MD USA
[3] Johnson & Johnson Pharmaceut Serv LLC, Malvern, PA USA
[4] Janssen Res & Dev LLC, Spring House, PA USA
[5] Centocor Ortho Biotech Serv LLC, Horsham, PA USA
[6] Centocor Res & Dev Inc, Malvern, PA USA
[7] Johns Hopkins Univ, Baltimore, MD USA
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 04期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A42 / A42
页数：1
相关论文
共 50 条
  • [41] The effect of intravenous golimumab on health-related quality of life and work productivity in adult patients with active ankylosing spondylitis: results of the phase 3 GO-ALIVE trial
    Reveille, John D.
    Hwang, Mark C.
    Danve, Abhijeet
    Kafka, Shelly
    Peterson, Steven
    Lo, Kim Hung
    Kim, Lilianne
    Hsia, Elizabeth C.
    Chan, Eric K. H.
    Deodhar, Atul
    CLINICAL RHEUMATOLOGY, 2021, 40 (04) : 1331 - 1341
  • [42] SOLIFENACIN SIGNIFICANTLY IMPROVES SYMPTOM BOTHER, HEALTH-RELATED QUALITY OF LIFE, AND OTHER PATIENT-REPORTED OUTCOMES IN PATIENTS WITH OVERACTIVE BLADDER: RESULTS FROM VIBRANT, A LARGE PLACEBO-CONTROLLED TRIAL
    Young, D. G.
    Samuels, T.
    Vardy, M. D.
    Gilmet, G.
    Marshall, T.
    Shannon, J.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 : 172 - 172
  • [43] Golimumab significantly improves health-related quality of life in patients with active ankytosing spondylitis: Results from the phase 3 GO-RAISE study
    van der Heijde, D.
    Deodhar, A.
    Braun, J.
    Mack, M.
    Parasuraman, S.
    Buchanan, J.
    Hsu, B.
    Beutler, A.
    Han, C.
    Inman, R. D.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S582 - S583
  • [44] Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial
    Simpson, Eric L.
    Silverberg, Jonathan I.
    Worm, Margitta
    Honari, Golara
    Masuda, Koji
    Sygu, Ewa
    Schuttelaar, Marie L. A.
    Mortensen, Eric
    Laws, Elizabeth
    Akinlade, Bolanle
    Patel, Naimish
    Maloney, Jennifer
    Paleczny, Heather
    Delevry, Dimittri
    Xiao, Jing
    Dubost-Brama, Ariane
    Bansal, Ashish
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (06) : 1190 - 1199
  • [45] A randomized placebo-controlled trial on the effect of high dose (intravenously) pamidronate on disease activity in patients with rheumatoid arthritis.
    Lodder, MC
    van Pelt, PA
    Kostense, PJ
    Lems, WF
    Koks, CHW
    Dijkmans, BAC
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S516 - S516
  • [46] SUSTAINED IMPROVEMENT IN HEALTH RELATED QUALITY OF LIFE, WORK PRODUCTIVITY, EMPLOYABILITY, AND REDUCED HEALTHCARE RESOURCE UTILIZATION OF PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS TREATED WITH GOLIMUMAB:5YR RESULTS
    Han, C.
    Kavanaugh, A.
    Genovese, M. C.
    Deodhar, A.
    Hsu, B.
    Hsia, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 337 - 337
  • [47] Effects of Alefacept on Health-Related Quality of Life in Patients with PsoriasisResults from a Randomized, Placebo-Controlled Phase II Trial
    Charles N. Ellis
    Margaret M. Mordin
    Ellen Y. Adler
    American Journal of Clinical Dermatology, 2003, 4 : 131 - 139
  • [48] Radiographic Progression Inhibition with Intravenous Golimumab in Psoriatic Arthritis: Week 24 Results of a Phase III, Randomized, Double-blind, Placebo-controlled Trial
    Kavanaugh, Arthur
    Husni, M. Elaine
    Harrison, Diane D.
    Kim, Lilianne
    Lo, Kim Hung
    Noonan, Lenore
    Hsia, Elizabeth C.
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (06) : 595 - 602
  • [49] Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
    Yoshiya Tanaka
    Kazuteru Wada
    Yoshinori Takahashi
    Owen Hagino
    Hubert van Hoogstraten
    Neil M. H. Graham
    Hideto Kameda
    Arthritis Research & Therapy, 21
  • [50] Final 5-Year Safety and Efficacy Results Of a Phase 3, Randomized Placebo-Controlled Trial Of Golimumab In Patients With Active Rheumatoid Arthritis Despite Prior Treatment With Methotrexate
    Keystone, Edward
    Genovese, Mark C.
    Hall, Stephen
    Miranda, Pedro
    Bae, Sang-Cheol
    Han, Chenglong
    Gathany, Timothy A.
    Zhou, Yiying
    Xu, Stephen
    Hsia, Elizabeth C.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S597 - S598
12345